Phase I study of liposomal annamycin.

Booser, D J; Perez-Soler, R; Cossum, P; Esparza-Guerra, L; Wu, Q P; Zou, Y; Priebe, W; Hortobagyi, G N

Booser, D J; Perez-Soler, R; Cossum, P; Esparza-Guerra, L; Wu, Q P; Zou, Y; Priebe, W; Hortobagyi, G N.

Affiliation

Booser DJ; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030-4095, USA.

Cancer Chemother Pharmacol ; 46(5): 427-32, 2000.

Article in En | MEDLINE | ID: mdl-11127949

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Doxorubicin/analogs & derivatives; Doxorubicin/therapeutic use; Neoplasms/drug therapy; Adult; Aged; Antibiotics, Antineoplastic/administration & dosage; Antibiotics, Antineoplastic/pharmacokinetics; Blood Cell Count; Dose-Response Relationship, Drug; Doxorubicin/administration & dosage; Doxorubicin/pharmacokinetics; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; Liposomes; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Antibiotics, Antineoplastic / Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2000 Document type: Article Affiliation country: United States Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links